Summary by Futu AI
Heart Test Laboratories, Inc., a company listed on The Nasdaq Stock Market, has announced a one-for-one hundred reverse stock split of its common stock and warrants. This corporate action was previously reported in a Form 8-K filed on May 10, 2024, and the Certificate of Amendment was filed with the Secretary of State of Texas on May 6, 2024. The reverse stock split will result in every one hundred shares of the pre-split issued and outstanding common stock being automatically converted into one post-split share. Fractional shares will be rounded up. The reverse stock split will take effect at the market open on May 17, 2024, with the common stock trading under the new CUSIP number 42254E302. The trading symbols for the common stock and public warrants will remain 'HSCS' and 'HSCSW' respectively. Adjustments will also be made to the company's outstanding warrants, with the exercise price per share of common stock attributable to the public warrants increasing to $425.00 post-split. The CUSIP for the public warrants will remain unchanged.
